Floatz logo

Bms-813160

Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) cohort.

Asset / SponsorPhaseRating
GVAX
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2CCC

Same molecule, other indications

Bms-813160 is also rated in:

cancerDormant
CCC
Indicative ·
54 / 100
View asset →
hepatocellular carcinomaDormant
CCC
Indicative ·
51 / 100
View asset →
non-small cell lung carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →